Name | HP1328 |
---|
Description | HP1328 is a potent inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1328 is a benzoimidazole scaffold-based compound. HP1328 significantly reduces the leukemia burden and prolongs the survival of mice with FLT3/ITD leukemia[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C23H23N3O3 |
---|---|
Molecular Weight | 389.45 |